×

img Acces sibility Controls

Technologies Banner

All Technologies

Clinical Decision Support Tool for Pre-emptive Screening of Alzheimer’s Disease

Implementing Organization

About

The product will be essentially an AI -based holistic risk prediction platform for early stage Alzheimer’s disease detection. Product incorporates two separate component- a) A salivary Lactoferrin (biomarker) detection kit & b) AI-based risk propensity prediction platform

Patents

In the process of filing

Outcome / Output

Early identification and management of the risk for Alzheimer’s in adult life will have a profound impact. Our platform aims to provide early detection and management of Alzheimer's risk, significantly reducing the disease burden and prolonging independence for individuals. By offering a cost-effective and efficient solution, it ensures rapid diagnosis and treatment, thereby revolutionizing elderly care and contributing to improved overall well-being in the aging population.
Quick Information
Thrust Areas
Medical Sciences
Focus Area
Frugal Innovation, Health
Status
Proof of Concept established
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…